TrialEuropean journal of clinical pharmacology2012

Hemodynamics and pharmacokinetics of tezosentan, a dual endothelin receptor antagonist, in patients with cirrhosis.

Didier Lebrec et al.PubMed ↗Publisher ↗

No numbers read from the abstract.